These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29354045)

  • 1. Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.
    Yang XQ; Lauzon B; Seergobin KN; MacDonald PA
    Front Hum Neurosci; 2017; 11():642. PubMed ID: 29354045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers.
    Yang XQ; Glizer D; Vo A; Seergobin KN; MacDonald PA
    Front Hum Neurosci; 2016; 10():523. PubMed ID: 27803657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic therapy affects learning and impulsivity in Parkinson's disease.
    Hiebert NM; Seergobin KN; Vo A; Ganjavi H; MacDonald PA
    Ann Clin Transl Neurol; 2014 Oct; 1(10):833-43. PubMed ID: 25493274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats.
    Jiménez-Urbieta H; Gago B; Quiroga-Varela A; Rodríguez-Chinchilla T; Merino-Galán L; Delgado-Alvarado M; Navalpotro-Gómez I; Belloso-Iguerategui A; Marin C; Rodríguez-Oroz MC
    Psychopharmacology (Berl); 2020 Aug; 237(8):2419-2431. PubMed ID: 32440779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment.
    Canário N; Sousa M; Moreira F; Duarte IC; Oliveira F; Januário C; Castelo-Branco M
    PLoS One; 2019; 14(2):e0210880. PubMed ID: 30759108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease.
    Jiménez-Urbieta H; Gago B; Quiroga-Varela A; Rodríguez-Chinchilla T; Merino-Galán L; Oregi A; Belloso-Iguerategui A; Delgado-Alvarado M; Navalpotro-Gómez I; Marin C; Fernagut PO; Rodríguez-Oroz MC
    Neurobiol Aging; 2019 Mar; 75():126-135. PubMed ID: 30572183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and Neuroanatomical Account of Impulsivity in Parkinson's Disease.
    Hlavatá P; Linhartová P; Šumec R; Filip P; Světlák M; Baláž M; Kašpárek T; Bareš M
    Front Neurol; 2019; 10():1338. PubMed ID: 31998210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
    Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA
    Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight gain after STN-DBS: The role of reward sensitivity and impulsivity.
    Aiello M; Eleopra R; Foroni F; Rinaldo S; Rumiati RI
    Cortex; 2017 Jul; 92():150-161. PubMed ID: 28494345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
    Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
    J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication.
    Murakami H; Momma Y; Nohara T; Mori Y; Futamura A; Sugita T; Ishigaki S; Katoh H; Kezuka M; Ono K; Miller MW; Kawamura M
    J Parkinsons Dis; 2016; 6(1):209-17. PubMed ID: 26889633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multidimensional approach to impulsivity in Parkinson's disease: measurement and structural invariance of the UPPS Impulsive Behaviour Scale.
    Bayard S; Joly E; Ghisletta P; Rossignol A; Herades Y; Geny C; Gély-Nargeot MC; Rochat L
    Psychol Med; 2016 Oct; 46(14):2931-2941. PubMed ID: 27460484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting state oscillations suggest a motor component of Parkinson's Impulse Control Disorders.
    Spay C; Meyer G; Lio G; Pezzoli G; Ballanger B; Cilia R; Boulinguez P
    Clin Neurophysiol; 2019 Nov; 130(11):2065-2075. PubMed ID: 31541984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopa therapy and action impulsivity: subthreshold error activation and suppression in Parkinson's disease.
    Fluchère F; Deveaux M; Burle B; Vidal F; van den Wildenberg WP; Witjas T; Eusebio A; Azulay JP; Hasbroucq T
    Psychopharmacology (Berl); 2015 May; 232(10):1735-46. PubMed ID: 25510855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?
    Houeto JL; Magnard R; Dalley JW; Belin D; Carnicella S
    Front Psychiatry; 2016; 7():91. PubMed ID: 27303314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pharmacological options for treating advanced Parkinson's disease.
    Devos D; Moreau C; Dujardin K; Cabantchik I; Defebvre L; Bordet R
    Clin Ther; 2013 Oct; 35(10):1640-52. PubMed ID: 24011636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss.
    Aarts E; Helmich RC; Janssen MJ; Oyen WJ; Bloem BR; Cools R
    Neuroimage; 2012 Feb; 59(4):3339-46. PubMed ID: 22166793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of Multiple Distinctive Neural Networks Associated With Impulse Control Disorder in Parkinson's Disease.
    Filip P; Linhartová P; Hlavatá P; Šumec R; Baláž M; Bareš M; Kašpárek T
    Front Hum Neurosci; 2018; 12():462. PubMed ID: 30519167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.